UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058085
Receipt number R000066386
Scientific Title Advance Care Planning (ACP) from the Perspective of Patients with Amyotrophic Lateral Sclerosis: A Qualitative Analysis Using the Grounded Theory Approach
Date of disclosure of the study information 2025/06/05
Last modified on 2025/06/05 03:54:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Advance Care Planning (ACP) from the Perspective of Patients with Amyotrophic Lateral Sclerosis: A Qualitative Analysis Using the Grounded Theory Approach

Acronym

Advance Care Planning (ACP) from the Perspective of Patients with Amyotrophic Lateral Sclerosis: A Qualitative Analysis Using the Grounded Theory Approach

Scientific Title

Advance Care Planning (ACP) from the Perspective of Patients with Amyotrophic Lateral Sclerosis: A Qualitative Analysis Using the Grounded Theory Approach

Scientific Title:Acronym

Advance Care Planning (ACP) from the Perspective of Patients with Amyotrophic Lateral Sclerosis: A Qualitative Analysis Using the Grounded Theory Approach

Region

Japan


Condition

Condition

amyotrophic lateral sclerosis

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Clarifying the ACP process for ALS patients from their perspective, with a view to the point at which they become unable to express their wishes.

Basic objectives2

Others

Basic objectives -Others

Clarify the process through interview surveys.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Discussions for when you are no longer able to express one's wishes

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with ALS by an IC, those who the referrer determines can be interviewed through conversation or other means of communication, and those classified as severity levels 2 to 4 in the severity classification.

Key exclusion criteria

Those whom the referrer judges to be mentally or psychologically difficult to interview for about one hour, or those who have difficulty in communicating in Japanese.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Atsuko
Middle name
Last name Furuta

Organization

University of Tsukuba

Division name

Graduate School of Comprehensive Human Science Doctoral & Master' s Program in Nursing Science

Zip code

305-0005

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki, Japan

TEL

0298590503

Email

s2330463@u.tsukuba.ac.jp


Public contact

Name of contact person

1st name Atsuko
Middle name
Last name Furuta

Organization

University of Tsukuba

Division name

Graduate School of Comprehensive Human Science Doctoral & Master' s Program in Nursing Science

Zip code

3050005

Address

1-1-1 Tennoudai, Tsukuba, Ibaraki, Japan

TEL

09086818630

Homepage URL


Email

s2330463@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Fumiko Yamaji Fund for Professional Nursing Education and Research

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee, University of Tsukuba Hospital

Address

2-1-1 Amakubo, Tsukuba, Ibaraki, Japan

Tel

0298533914

Email

rinshokenkyu@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 11 Month 20 Day

Date of IRB

2024 Year 11 Month 28 Day

Anticipated trial start date

2024 Year 11 Month 28 Day

Last follow-up date

2025 Year 10 Month 24 Day

Date of closure to data entry

2025 Year 10 Month 24 Day

Date trial data considered complete

2025 Year 10 Month 24 Day

Date analysis concluded



Other

Other related information

Follow the interview guide and ask the following questions:

What to expect after being diagnosed with ALS
Discussions about what kind of life and medical care you would like to receive based on what is important to you and your life goals since diagnosis
What and with whom and when were these discussions held?
How you perceived your experience with ALS at that time
What did you think about your life after being diagnosed with ALS based on your knowledge of the disease?
Have you ever found it difficult to tell others about your disease? If so, who did you find it difficult to tell and why?
Were discussions ongoing and why were they ongoing?
What or who did you want to tell in preparation for the time when you are no longer able to express your feelings


Management information

Registered date

2025 Year 06 Month 05 Day

Last modified on

2025 Year 06 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066386